UCBJF:OTCMKTS
UCB SA
$239.14
arrow_downward
-0.46%(-1.10) 1D
Okt 16, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa UCBJF...
Buksan
$239.14
Mataas
$239.14
Mababa
$239.14
Mkt. cap
39.39B
Avg. na dami
127.00
Dami
107.00
Mataas nang 52-wk
$345.39
Mababa nang 52-wk
$219.60
Beta
0.58
Mga natitirang share
194.51M
Bilang ng mga empleyado
9K
Buksan
$239.14
Mataas
$239.14
Mababa
$239.14
Mkt. cap
39.39B
Avg. na dami
127.00
Dami
107.00
Mataas nang 52-wk
$345.39
Mababa nang 52-wk
$219.60
Beta
0.58
Mga natitirang share
194.51M
Bilang ng mga empleyado
9K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
20 oras ang nakalipas
UCB launches Wear It Out: what it means for UCB stock
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Tungkol sa UCB SA